Publication | Closed Access

Effects of Eicosapentaenoic Acid on Asymmetric Dimethylarginine in Patients in the Chronic Phase of Cerebral Infarction: A Preliminary Study

Cerebrovascular DiseasePharmacotherapyCerebral Vascular RegulationThrombosisStrokeEicosapentaenoic AcidBrain InjuryNeurologyPublic HealthAtherosclerosisIschemic SyndromeCerebral InfarctionCerebral Blood FlowReperfusion InjuryPharmacologyCardiovascular DiseaseStroke-related ConditionMedicineAsymmetric Dimethylarginine